A second hep C article in the Inquirer this June - it’s great to see more local awareness being raised about this health issue!
The Food and Drug Administration warned Friday that doctors should not prescribe and patients should not use the hepatitis C drug Victrelis (boceprevir) and the anti-HIV drug ritonavir at the same time because such use reduces the effectiveness of both drugs.
“‘The only appropriate motivation should be what is the best and fastest way to get cures, not what is best for the shareholders,’ said Dr. Scott Friedman, chief of liver diseases at the Mount Sinai School of Medicine in New York…” Read more here.
